Go Deep
Chordia Therapeutics Inc.
Chordia Therapeutics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,173 | -2.5 | 1.61 | 0.00 | 30.27 |
Chordia Therapeutics Inc. Quarterly Results
| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -413,985,000.0 | -338,381,000.0 | -295,322,000.0 | -386,515,000.0 |
| EPS | — | — | -4.2 | — |
Chordia Therapeutics Inc. Revenue & Profit: Last 5 Years
| Line Item | Aug 2026 | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 |
|---|---|---|---|---|---|
| Revenue | — | 0.0 | 0.0 | 2,500,000,000.0 | 0.0 |
| Net Profit | — | -1,785,867,000.0 | -1,827,127,000.0 | 223,341,000.0 | -1,779,060,000.0 |
| EPS | — | -26.0 | -31.1 | 4.0 | -31.5 |
Chordia Therapeutics Inc. Balance Sheet
| Line Item | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 |
|---|---|---|---|---|
| Total Assets | 2,681,349,000.0 | 4,632,370,000.0 | 4,909,123,000.0 | 4,498,947,000.0 |
| Total Liabilities | 244,339,000.0 | 471,073,000.0 | 408,242,000.0 | 221,408,000.0 |
| Total Equity | 2,437,009,000.0 | 4,161,296,000.0 | 4,500,881,000.0 | 4,277,539,000.0 |
Owes vs Owns
Chordia Therapeutics Inc. owed ¥0.10 for every ¥1 it owned in May 2026, up from ¥0.05 in Aug 2022.
| Period | May 2026 | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.10× | 0.09× | 0.10× | 0.08× | 0.05× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Chordia Therapeutics Inc. Assets & Liabilities Breakdown (JPY millions)
What it owns — Aug 2025
Cash & short-term investments 95.1%Other assets 4.9%
How it's funded — Aug 2025
Payables 5.5%Other liabilities 3.6%Shareholders' equity 90.9%
| Line Item | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,549.0 | 4,329.6 | 4,799.0 | 4,255.0 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 2.7 | 4.4 | 8.2 |
| Intangible assets | 0.0 | 0.6 | 2.5 | 4.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 132.4 | 299.4 | 103.2 | 231.7 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 148.7 | 436.7 | 250.9 | 140.0 |
| Other liabilities | 95.6 | 34.4 | 157.4 | 81.4 |
| Shareholders' equity | 2,437.0 | 4,161.3 | 4,500.9 | 4,277.5 |
| Net tangible assets | 2,437.0 | 4,160.7 | 4,498.4 | 4,273.5 |
Chordia Therapeutics Inc. Cash Flow
| Line Item | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 |
|---|---|---|---|---|
| Operating Activities | -1,836,921,000.0 | -1,937,248,000.0 | 543,731,000.0 | -1,704,131,000.0 |
| Investing Activities | -5,327,000.0 | -10,959,000.0 | 345,000.0 | -14,696,000.0 |
| Financing Activities | 61,580,000.0 | 1,478,797,000.0 | 0.0 | 3,975,637,000.0 |